Virtual Medicinal Product (VMP) - Beractant 200mg/8ml endotracheopulmonary suspension bottles
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Beractant 200mg/8ml endotracheopulmonary suspension bottles | Start Date 17-09-2004 | End Date |
| Previous Name | Previous Name Beractant 200mg/8ml endotracheopulmonary instillation suspension bottles | Start Date 23-08-2004 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 8.0
- UDFS UOM
- ml
- Unit Dose UOM
- bottle
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Endotracheopulmonary
- Form
- Suspension for endotracheopulmonary instillation
- Ontology Form/Route
- suspension.endotracheopulmonary
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- n/a
- BNF Codes
-
- BNF code 03050200
| Code | Start Date | End Date |
|---|---|---|
| 35892811000001109 | 17-10-2018 | |
| 320908000 | 23-08-2004 | 16-10-2018 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Beractant | Based on Base Substance | Phospholipids | 25 mg | 1 ml |
Name
Beractant
Basis of strength description
Based on Base Substance
BOSS
Phospholipids
Strength and UOM (Nmr)
25.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMBeractant
-
VMP(Current) Beractant 200mg/8ml endotracheopulmo...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 bottle |